Published 15 hours ago • loading... • Updated 6 hours ago

MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO

Colby Holtshouse has been appointed as President and CEO of May Health, which focuses on treatments for Polycystic Ovary Syndrome .
May Health completed a $25M Series B funding round, co-led by Trill Impact and BPI France, which follows an earlier €10M Series A round.
May Health is conducting the REBALANCE study to support marketing authorization for its Ovarian Rebalancing procedure, aimed at helping women with PCOS-related infertility.
Polycystic Ovary Syndrome affects about 10% of reproductive-aged women and is a leading cause of infertility, which May Health is addressing with its Ovarian Rebalancing procedure.

Insights by Ground AI

Does this summary seem wrong?

55 Articles

All

Left

Center

Right

Inside Ottawa Valley

+2 Reposted by 2 other sources

ATIS Appoints Jim Fox as CEO to Lead Next Phase of Growth

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- ATIS, a premier provider of elevator and escalator safety inspections, consulting, and managed services, is pleased to announce the appointment of Jim Fox as CEO.

10 hours ago·Ottawa, Canada

Read Full Article

Buffalo News

+51 Reposted by 51 other sources

MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO

Leadership transition comes as Company focuses on clinical evaluation of its novel Ovarian Rebalancing™ technology, a one-time transvaginal ablation procedure designed to restore ovulation in women with PCOS, a leading cause of infertility

15 hours ago·Buffalo, United States

Read Full Article

Buffalo News